Bausch + Lomb CorporationBausch + Lomb CorporationBausch + Lomb Corporation

Bausch + Lomb Corporation

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪5.35 B‬USD
‪−260.00 M‬USD
‪4.15 B‬USD
‪38.31 M‬
Beta (1Y)

About Bausch + Lomb Corporation

Brenton L. Saunders
Employees (FY)
‪13.3 K‬
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.
Revenue to profit conversion
Debt level and coverage
Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BLCO is 15.35 USD — it has increased by 0.69% in the past 24 hours. Watch Bausch + Lomb Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Bausch + Lomb Corporation stocks are traded under the ticker BLCO.
BLCO stock has risen by 4.39% compared to the previous week, the month change is a 2.85% rise, over the last year Bausch + Lomb Corporation has showed a 13.65% decrease.
We've gathered analysts' opinions on Bausch + Lomb Corporation future price: according to them, BLCO price has a max estimate of 25.00 USD and a min estimate of 14.00 USD. Watch BLCO chart and read a more detailed Bausch + Lomb Corporation stock forecast: see what analysts think of Bausch + Lomb Corporation and suggest that you do with its stocks.
BLCO reached its all-time high on Jun 30, 2023 with the price of 21.95 USD, and its all-time low was 12.20 USD and was reached on Jul 28, 2022. View more price dynamics on BLCO chart.
See other stocks reaching their highest and lowest prices.
BLCO stock is 1.51% volatile and has beta coefficient of 1.01. Track Bausch + Lomb Corporation stock price on the chart and check out the list of the most volatile stocks — is Bausch + Lomb Corporation there?
Today Bausch + Lomb Corporation has the market capitalization of ‪5.35 B‬, it has increased by 3.60% over the last week.
Yes, you can track Bausch + Lomb Corporation financials in yearly and quarterly reports right on TradingView.
Bausch + Lomb Corporation is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
BLCO earnings for the last quarter are 0.07 USD per share, whereas the estimation was 0.07 USD resulting in a −0.49% surprise. The estimated earnings for the next quarter are 0.14 USD per share. See more details about Bausch + Lomb Corporation earnings.
Bausch + Lomb Corporation revenue for the last quarter amounts to ‪1.09 B‬ USD despite the estimated figure of ‪1.06 B‬ USD. In the next quarter revenue is expected to reach ‪1.17 B‬ USD.
BLCO net income for the last quarter is ‪−167.00 M‬ USD, while the quarter before that showed ‪−54.00 M‬ USD of net income which accounts for −209.26% change. Track more Bausch + Lomb Corporation financial stats to get the full picture.
No, BLCO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 30, 2024, the company has ‪13.30 K‬ employees. See our rating of the largest employees — is Bausch + Lomb Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bausch + Lomb Corporation EBITDA is ‪613.00 M‬ USD, and current EBITDA margin is 14.13%. See more stats in Bausch + Lomb Corporation financial statements.
Like other stocks, BLCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bausch + Lomb Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bausch + Lomb Corporation technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bausch + Lomb Corporation stock shows the sell signal. See more of Bausch + Lomb Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.